SCHEMBL30643174

SCHEMBL30643174

CCCC(C)c1ccc(C=O)o1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.44
HTT P42858 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
GAA P10253 1/20 0.40
TSHR P16473 1/20 0.40
SMN1; SMN2 Q16637 5/20 0.36
MAPT P10636 3/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
STAT1 P42224 1/20 0.36
KDM4E B2RXH2 4/20 0.35
HSP90AA1 P07900 1/20 0.35
POLB P06746 4/20 0.33
LMNA P02545 2/20 0.33
HPGD P15428 2/20 0.32
TP53 P04637 1/20 0.32
HCAR2 Q8TDS4 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
CYP2E1 P05181 1/20 0.30
CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17512074 0.80 TBXA2R (0.39) ALDH1A1HTTL3MBTL1GAATSHR
SCHEMBL10635461 0.80 ALDH1A1 (0.43) ALDH1A1HTTL3MBTL1GAATSHR
SCHEMBL10147239 0.76 GAA (0.48) ALDH1A1HTTL3MBTL1GAATSHR
SCHEMBL19102366 0.74 HCAR2 (0.32) SMN1; SMN2HCAR2CA12CA2CA9
SCHEMBL28811654 0.72 GAA (0.45) ALDH1A1HTTL3MBTL1GAATSHR
SCHEMBL5596655 0.72 ALDH1A1 (0.45) ALDH1A1HTTL3MBTL1GAATSHR
SCHEMBL22289270 0.72 ALDH1A1 (0.46) ALDH1A1HTTL3MBTL1GAATSHR
SCHEMBL8640022 0.68 ALDH1A1 (0.61) ALDH1A1HTTL3MBTL1GAATSHR
SCHEMBL18793177 0.68
SCHEMBL14210010 0.68 HCAR2 (0.30) HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250289795-A1 METHOD FOR PREPARATION OF COMPOUND POSSESSING 5-PENTYLFURFURAL (5-PF) STRUCTURE AND USE THEREOF FUGENBIO CO., LTD. (KR) 2025-09-18 US disclosed
EP-4516783-A1 METHOD FOR PREPARATION OF COMPOUND POSSESSING 5-PENTYLFURFURAL (5-PF) STRUCTURE AND USE THEREOF Fugenbio Co., Ltd. (KR) 2025-03-05 EP disclosed
WO-2023211205-A1 METHOD FOR PREPARATION OF COMPOUND POSSESSING 5-PENTYLFURFURAL (5-PF) STRUCTURE AND USE THEREOF (주)퓨젠바이오 2023-11-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250289795-A1 METHOD FOR PREPARATION OF COMPOUND POSSESSING 5-PENTYLFURFURAL (5-PF) STRUCTURE AND USE THEREOF FABP4, FABP5, PLIN5 ALDH1A1 236/4885HTT 2436/4885L3MBTL1 3614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.